Expert Consensus on the use of autologous platelet-rich plasma in the context of regenerative medicine: moving forward to good clinical practice.

Key Points

• The aim is to clarify the use of autologous platelet-rich plasma (PRP) in regenerative medicine and establish good clinical practices.
• Encouragement of multicentre research initiatives
• Recommendations for strict publication standards
• Promotion of international collaboration
• Strengthened scientific foundations for the application of PRP
• Guidelines for effective clinical practices in regenerative medicine

Abstract